NCT07353840
- Conditions
- Disease Attributes, Disease Progression, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Lymphoma, T-Cell, Peripheral
Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.
235 public trials
60 recruiting studies
Lymphoma, T-Cell, Peripheral trial results
NCT06776952
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China
NCT07093710
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, Guangdong, China
NCT07253129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Recruiting
Amping up With PemJAK
NCT07283822
- Conditions
- Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
NCT06421948
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
- Liling Zhang Wuhan, Hubei, China
- Yajun Li Changsha, Hunan, China
- Ming Jiang Chengdu, Sichuan, China
NCT07162012
- Conditions
- DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Shanghai General Hospital Shanghai, China
NCT06733441
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Stanford Cancer Institute Stanford, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
Recruiting
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
NCT04234048
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
- Locations
-
- Mayo Clinic Arizona Scottsdale, Arizona, United States
- City of Hope Medical Foundation Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
NCT04083495
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
- Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States